Stay updated on Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial page.

Latest updates to the Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial page
- CheckyesterdayChange DetectedTaiwan location entry updated: Taoyuan District, Taiwan, 333 was removed and Taoyuan, Taiwan, 333 was added, reflecting a rename/relocation in the study's locations list.SummaryDifference0.0%

- Check8 days agoChange DetectedRevision: v3.5.3 is now displayed, replacing Revision: v3.5.2. This represents an updated revision of the included document without changing the study details visible to users.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now displays Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

- Check30 days agoChange DetectedPadova, Italy (35128) is now listed as a study location, replacing Padua, Italy (35128).SummaryDifference0.0%

- Check37 days agoChange DetectedAdded the related topic Squamous cell carcinoma of the head and neck and included the Genetic and Rare Diseases Information Center as a resource.SummaryDifference0.1%

- Check44 days agoChange DetectedNaples, Italy, 80121 was added and Napoli, Italy, 80121 was removed, and the revision tag changed from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial page.